Authors:

I Putu Ary Wismayana, Elysanti Dwi Martadiani, Lisna Astuti

Abstract:

“Thyroid cancer prevalence tend to increase, by 2008 there are 37.340 cases with mortality rate reached 1.590. Traditionally USG and scintigraphy are major imaging modality to diagnose or predict the prognosis of thyroid cancer. On special case, ultrasonography or scintigraphy cannot be use due to anatomical change after surgical procedure or low iodine uptake. Positron-Emission Tomography (PET) is noninvasive, three-dimensional, nuclear imaging technique. PET can evaluate both anatomical and functional. 18F-Flourodeoxyglucose PET can evaluate function and abnormality of thyroid which cannot be evaluated using another imaging modalities. PET can detect papillary and follicular thyroid cancer relaps with negative increasing thyroglobuline and radioiodine scanning negative, instead of detects medularry thyroid cancer earlier. Benefits of PET limited due to cost and technology.”

Keywords

Keyword Not Available

Downloads:

Download data is not yet available.

References

References Not Available

PDF:

https://jurnal.harianregional.com/eum/full-5808

Published

2021-11-09

How To Cite

ARY WISMAYANA, I Putu; DWI MARTADIANI, Elysanti; ASTUTI, Lisna. 18F-FLOURODEOXYGLUCOSE (18FDG) POSITRON-EMISSION TOMOGRAPHY (PET) AS IMAGING MODALITIES ON THYROID CANCER MANAGEMENT.E-Jurnal Medika Udayana, [S.l.], p. 1127-1142, july 2013. ISSN 2303-1395. Available at: https://jurnal.harianregional.com/eum/id-5808. Date accessed: 08 Jul. 2024.

Citation Format

ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

Issue

vol 2 no 7 (2013):e-jurnal medika udayana

Section

Articles

Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License